Physician profile
Tim Fischell
NPI 1891771440
$468,073.70
in general payments reported to CMS, 2019-2025
49 companies · $1,748 in 2025
The $1,748 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87K · 2020: $30K · 2021: $276K · 2022: $21K · 2023: $43K · 2024: $10K · 2025: $1,748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $48K · Food and Beverage: $5,647 · Acquisitions: $1,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $47,994.21 |
| Food and Beverage | $5,647.24 |
| Acquisitions | $1,373.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $248,123.46 | 2021-2023 | |
| Cordis Corporation | $88,211.96 | 2019-2021 | |
| Medtronic Vascular, INC. | $51,430.48 | 2019 | |
| Cordis US Corp. | $42,047.76 | 2022-2025 | Radial 360, Mynxgrip, Selution Slrpta |
| Avertix Medical, INC | $24,210.03 | 2023-2024 | |
| Merit Medical Systems INC | $3,785.13 | 2019-2022 | |
| Abbott Laboratories | $2,148.90 | 2019-2025 | Amplatzer Amulet, Optis, Dragonfly Opstar |
| Boston Scientific Corporation | $1,084.85 | 2019-2025 | Avvigo Guidance System, General - Thrombectomy, Watchman Access System |
| Shockwave Medical, INC | $1,065.14 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $680.29 | 2019-2025 | Indigo System |
| Abiomed | $594.83 | 2019-2025 | Impella |
| Medtronic, INC. | $493.54 | 2022-2025 | Symplicity G3, Ffrangio, Linq II |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $454.26 | 2020-2025 | Lifevest |
| Stryker Corporation | $366.21 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Inari Medical, INC. | $343.02 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $307.97 | 2022-2025 | Kengreal, Cleviprex |
| Novartis Pharmaceuticals Corporation | $300.85 | 2019-2025 | |
| Heartflow, INC. | $281.06 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $190.26 | 2021-2025 | Eliquis, Camzyos |
| Kestra Medical Technology Services, INC. | $167.12 | 2023-2024 | Assure Wcd |
| Angiodynamics, INC. | $157.75 | 2022-2024 | Alphavac |
| Amgen INC. | $156.50 | 2019-2024 | Repatha |
| Recor Medical INC | $147.11 | 2025 | Paradise Ultrasound Renal Denervation System |
| Janssen Pharmaceuticals, INC | $146.77 | 2023-2024 | Xarelto |
| Opsens INC. | $144.79 | 2021 | |
| Cardinal Health 200 LLC | $142.26 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $134.40 | 2019-2025 | Wainua, Brilinta, Farxiga |
| Terumo Medical Corporation | $124.97 | 2019 | |
| Philips North America LLC | $119.42 | 2020-2021 | |
| Edwards Lifesciences Corporation | $105.62 | 2025 | Sapien 3 Ultra Resilia |
| Actelion Pharmaceuticals US, INC. | $61.39 | 2023-2025 | Opsumit, Uptravi, Opsynvi |
| Nipro Medical Corporation | $61.14 | 2025 | Hemodialysis System |
| Teleflex LLC | $51.37 | 2023-2025 | Supercross, Guideliner, Manta |
| Zoll Circulation INC | $37.58 | 2023-2024 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Cardiva Medical, INC. | $33.26 | 2024 | Savvywire |
| Imperative Care, INC | $30.50 | 2024 | Symphony Catheter |
| Novo Nordisk INC | $27.70 | 2025 | Wegovy |
| Biosense Webster, INC. | $24.72 | 2022 | |
| W. L. Gore & Associates, INC. | $20.58 | 2024 | Gore Excluder Aaa Endoprosthesis |
| Kiniksa Pharmaceuticals International, Plc | $19.46 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.72 | 2019 | |
| Acist Medical Systems, INC. | $13.68 | 2024 | |
| Cardiovascular Systems INC. | $8.89 | 2019 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,102,584.92 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tim Fischell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.